GlassScriptPhysician profile
Suly Brea
NPI 1154056414
$5,219.45
in general payments reported to CMS, 2019-2025
32 companies · $1,907 in 2025
The $1,907 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $93.04 · 2023: $1,424 · 2024: $1,796 · 2025: $1,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,126.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $664.66 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Astrazeneca Pharmaceuticals LP | $493.53 | 2022-2025 | Farxiga, Wainua, Lokelma |
| Merck Sharp & Dohme LLC | $389.74 | 2023-2025 | Verquvo, Winrevair, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $372.09 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $332.17 | 2023-2025 | Jardiance |
| Amgen INC. | $317.73 | 2022-2025 | Repatha, Repatha |
| Cvrx, INC. | $273.99 | 2023-2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $272.22 | 2023-2025 | |
| Pfizer INC. | $209.57 | 2023-2025 | |
| Abbott Laboratories | $192.64 | 2023-2025 | Cardiomems, Amplatzer Amulet, Aveir |
| Alnylam Pharmaceuticals INC. | $187.73 | 2022-2025 | Onpattro |
| United Therapeutics Corporation | $176.29 | 2023-2025 | Tyvaso, Tyvaso |
| Bridgebio Pharma, INC. | $132.80 | 2025 | Attruby |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.21 | 2023-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $95.89 | 2024 | Arcalyst |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $88.95 | 2024-2025 | Impella |
| Heartflow, INC. | $88.44 | 2023 | Ffrct |
| Bayer Healthcare Pharmaceuticals INC. | $85.97 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $85.10 | 2024 | |
| Janssen Pharmaceuticals, INC | $69.60 | 2023-2024 | Xarelto |
| Medtronic, INC. | $69.20 | 2023-2025 | Micra, Aurora Ev-Icd Mri Surescan |
| Novo Nordisk INC | $67.96 | 2024-2025 | Ozempic |
| Boston Scientific Corporation | $66.03 | 2025 | Watchman Flx |
| Esperion Therapeutics, INC. | $64.92 | 2024-2025 | Nexletol |
| Agepha Pharma Fz LLC | $59.39 | 2024-2025 | Lodoco |
| Sanofi-Aventis U.S. LLC | $47.68 | 2023-2024 | |
| Kowa Pharmaceuticals America, INC. | $40.45 | 2023-2024 | Livalo |
| Stryker Corporation | $35.61 | 2025 | Flowtriever |
| Edwards Lifesciences Corporation | $33.66 | 2025 | |
| Inari Medical, INC. | $28.99 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Biotronik INC. | $22.38 | 2024 | |
| Zoll Circulation INC | $21.86 | 2023-2024 | Catheter, Downstream Cartridge, Therox Ds2 Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suly Brea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.